Dan Lynch is a venture capital investor at Google Ventures who stands out for his unusually extensive hands-on biotech leadership experience, having served as CFO, CEO, and executive chair across 16 companies since 2011, giving him a multi-decade view of how drug companies are built rather than just financed. He explicitly focuses his investments on companies with broad patient impact potential rather than just financial returns, and works at GV as their first Executive Venture Partner in a coaching-focused role designed around mentoring biotech founders on leadership and business development.